Jeffrey Gray is a prostate cancer survivor, thanks to the minimally invasive surgery he received from urology specialist Michael J. Whalen, MD, at the GW Cancer Center. Now he’s back to doing the things he loves.
A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
Elmer Huerta, MD, MPH, director of the Cancer Preventorium at the George Washington University Cancer Center, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.